Federal judge triples damages against Lilly in whistleblower suit – Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.
A judge ruled that Indianapolis-based Lilly was liable for higher payments due to its behavior in making false statements to the Centers for Medicare and Medicaid Services about the prices it charged distributors for its drugs.
Lilly to pay more than $180mn for defrauding US Medicaid Program europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Litigation involving drug price reporting under the Medicaid Drug Rebate Program (MDRP)1 has been very active in 2022. Most recently, on August 3, 2022, an Illinois federal jury.